Participation to the BQC19 allows researchers to work with human specimens from individuals infected with the SARS-CoV-2 virus responsible for COVID-19 and uninfected controls to try to elucidate the causes and mechanisms of severity. The availability of high-quality, well-documented human biological materials is essential to improve the understanding of COVID-19 and to stimulate the development of new therapeutic options, including vaccine development and monitoring.
Consent must be obtained from the BQC19 participant or his or her legal representative, if the participant is a minor or incompetent. Consent must be given voluntarily and without coercion, be informed (given after receiving all necessary information) and documented. In the context of patients hospitalized for COVID-19, it is possible that the person may be contacted by telephone to obtain consent according to the ethical standards established by the hospital institution.
Collection and conservation
Standardized protocols for sample collection, processing and storage that comply with good practice guidelines provide access to quality biological samples and ensure efficient and sustainable use.
Secure database and network
Protecting the confidentiality of information and the identity of participants is a priority at all times. All the BQC19 data is encrypted and denominated and stored on a secure server. Only a few authorized persons have access to this server, which is protected by an access code. In addition, daily back-ups of the data are made.
Scientific and ethical approval
Any use of biological samples or data from the BQC19 requires acceptance of the research project by the Biobank Access Committee and a duly established Ethics Committee. Once these approvals and authorization to carry out the project have been received, the BQC19 team may transmit the material and data requested. The approval and monitoring of a research project by a Research Ethics Committee constitutes a guarantee of security for participants.
Depending on the availability of the material requested, the BQC19 team selects the biological samples and associated data that meet the inclusion and exclusion criteria contained in the protocol submitted by the investigator.